QUANTERIX
Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The company’s ultra-sensitive detection solution, Simoa, ... has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.
QUANTERIX
Industry:
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2007-01-01
Address:
Billerica, Massachusetts, United States
Country:
United States
Website Url:
http://www.quanterix.com
Total Employee:
251+
Status:
Active
Contact:
617-301-9400
Total Funding:
533.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Quantum SI
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Current Advisors List
Board_member
2014-06-01
Board_member
Board_member
Board_member
Board_member
Board_member
2010-09-01
Current Employees Featured
Andreas Jeromin Chief Medical Officer @ Quanterix
Chief Medical Officer
2013-12-01
Michael A. Doyle Chief Financial Officer @ Quanterix
Chief Financial Officer
David R. Walt Scientific Founder & Board Director @ Quanterix
Scientific Founder & Board Director
Scott Douglas Sr Director, Technical Development @ Quanterix
Sr Director, Technical Development
2018-03-01
Mike Gilmore Associate Director of Software Engineering @ Quanterix
Associate Director of Software Engineering
2020-01-01
Amol Chaubal Chief Financial Officer @ Quanterix
Chief Financial Officer
2019-04-01
Joel Nichols Senior Vice President Digital & Information Technologies @ Quanterix
Senior Vice President Digital & Information Technologies
2021-06-01
Mary Cortizas Clinical Development Strategy @ Quanterix
Clinical Development Strategy
2018-10-01
Mary Cortizas Vice President of CRO and Laboratory Services @ Quanterix
Vice President of CRO and Laboratory Services
2019-01-01
Darrin Crisitello Chief Commercial Officer (CCO) @ Quanterix
Chief Commercial Officer (CCO)
2021-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-26 | UmanDiagnostics | UmanDiagnostics acquired by Quanterix | 22.5 M USD |
Investors List
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Quanterix
T. Rowe Price
T. Rowe Price investment in Series D - Quanterix
Hercules Capital
Hercules Capital investment in Series D - Quanterix
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Quanterix
ARCH Overage Fund
ARCH Overage Fund investment in Series D - Quanterix
Tufts University
Tufts University investment in Series D - Quanterix
Bain Capital Ventures
Bain Capital Ventures investment in Series D - Quanterix
Cormorant Asset Management
Cormorant Asset Management investment in Series D - Quanterix
Trinitas Capital
Trinitas Capital investment in Series D - Quanterix
bioMerieux
bioMerieux investment in Series C - Quanterix
Key Employee Changes
| Date | New article |
|---|---|
| 2020-11-19 | Quanterix appoints chief operating officer |
Official Site Inspections
http://www.quanterix.com Semrush global rank: 241.55 K Semrush visits lastest month: 291.99 K
- Host name: ec2-34-199-95-206.compute-1.amazonaws.com
- IP address: 34.199.95.206
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Quanterix"
Meet the Team - Quanterix
In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time. info@quanterix.com 617 301 9400 900 Middlesex TPKE …See details»
Quanterix - Crunchbase Company Profile & Funding
Organization. Quanterix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Quanterix is a …See details»
Ultra-Sensitive Biomarker Detection | Quanterix
In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time. info@quanterix.com 617 301 9400 900 Middlesex TPKE …See details»
Quanterix Profile | The Scientist
Content provided by Quanterix. Sex Differences in Neurological Research. Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro …See details»
Quanterix Corporation (QTRX)
See the company profile for Quanterix Corporation (QTRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Quanterix - Funding, Financials, Valuation & Investors - Crunchbase
Quanterix is registered under the ticker NASDAQ:QTRX . Their stock opened with $15.00 in its Dec 6, 2017 IPO. Quanterix is funded by 12 investors. Alzheimer's Drug Discovery Foundation …See details»
Quanterix Corporation - AnnualReports.com
Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa®, has the potential to change the way in which healthcare is provided …See details»
Presentations | Investor Relations | Quanterix
33 rows Presentations | Investor Relations | QuanterixSee details»
Quanterix Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The Company’s ultra-sensitive detection solution, …See details»
Quanterix Releases Operating Results for Fourth Quarter and Full …
BILLERICA, Mass. – February 29, 2024 – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced …See details»
Quanterix Appoints Vandana Sriram as Chief Financial Officer
Aug 9, 2023 BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics …See details»
Quanterix Corporation (QTRX) - Yahoo Finance Canada
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and …See details»
Quanterix - Overview, News & Similar companies | ZoomInfo.com
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery …See details»
Quanterix Provides Update on Financial Performance
Quanterix also announced that it will release its fourth quarter and full year 2024 financial results on Monday, March 17, 2025. About Quanterix. From discovery to diagnostics, Quanterix’s …See details»
Quanterix To Report Fourth Quarter and Full Year 2024 Financial …
BILLERICA, Mass. – March 13, 2025 – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it …See details»
Working at Quanterix - Glassdoor
Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. Our digital health solution, Simoa, has the potential to change the way in …See details»
Quanterix: Still Many, Many Questions - Seeking Alpha
2 days ago Summary. Quanterix, a life sciences company, went public in 2017 and has grown sales from $25 million to about $140 million by now, although accompanied by continuous …See details»
Quanterix Highlights Compelling Benefits of Akoya Biosciences ...
BILLERICA, Mass. March 3, 2025 — Quanterix Corporation (NASDAQ: QTRX) (“Quanterix” or the “Company”), a company fueling scientific discovery through ultra-sensitive biomarker …See details»
Quanterix Releases Financial Results for the Fourth Quarter of 2024
Mar 17, 2025 Delivers seventh consecutive quarter of double-digit revenue growth. BILLERICA, Mass. – March 17, 2025 – Quanterix Corporation (NASDAQ: QTRX), a company fueling …See details»
Quanterix Corporation Releases Operating Results for Second …
BILLERICA, Mass.–(BUSINESS WIRE)–Aug. 8, 2022– Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today …See details»